Concepts (137)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnesium | 6 | 2023 | 178 | 1.690 |
Why?
|
| Cation Transport Proteins | 5 | 2023 | 70 | 1.440 |
Why?
|
| Bacterial Proteins | 10 | 2023 | 922 | 1.410 |
Why?
|
| Thermotoga maritima | 4 | 2016 | 16 | 1.290 |
Why?
|
| ATP-Binding Cassette Transporters | 5 | 2005 | 142 | 0.810 |
Why?
|
| Models, Molecular | 7 | 2016 | 1375 | 0.680 |
Why?
|
| Ion Channel Gating | 3 | 2012 | 338 | 0.610 |
Why?
|
| Membrane Transport Proteins | 3 | 2005 | 170 | 0.460 |
Why?
|
| Bacillus subtilis | 3 | 2004 | 92 | 0.440 |
Why?
|
| Ion Channels | 2 | 2023 | 260 | 0.420 |
Why?
|
| Electron Spin Resonance Spectroscopy | 3 | 2012 | 329 | 0.410 |
Why?
|
| Cell Membrane Permeability | 1 | 2014 | 121 | 0.410 |
Why?
|
| Protein Conformation | 6 | 2023 | 935 | 0.400 |
Why?
|
| Potassium Channels | 2 | 2012 | 359 | 0.390 |
Why?
|
| Lipid Bilayers | 2 | 2015 | 147 | 0.330 |
Why?
|
| Bacterial Outer Membrane Proteins | 2 | 2019 | 57 | 0.330 |
Why?
|
| Drug Resistance, Bacterial | 3 | 2005 | 84 | 0.320 |
Why?
|
| Cell Membrane | 2 | 2007 | 696 | 0.260 |
Why?
|
| Escherichia coli | 4 | 2019 | 627 | 0.240 |
Why?
|
| Adenosine Triphosphate | 2 | 2004 | 329 | 0.240 |
Why?
|
| Gene Editing | 2 | 2023 | 52 | 0.230 |
Why?
|
| p-Dimethylaminoazobenzene | 1 | 2005 | 1 | 0.230 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2005 | 101 | 0.220 |
Why?
|
| Dactinomycin | 1 | 2004 | 35 | 0.220 |
Why?
|
| Amino Acid Sequence | 5 | 2014 | 2092 | 0.220 |
Why?
|
| Antigens, Neoplasm | 2 | 2023 | 359 | 0.210 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2023 | 432 | 0.200 |
Why?
|
| Sequence Alignment | 3 | 2014 | 360 | 0.200 |
Why?
|
| Glutamic Acid | 1 | 2003 | 159 | 0.200 |
Why?
|
| Conserved Sequence | 1 | 2003 | 215 | 0.190 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2022 | 59 | 0.190 |
Why?
|
| Static Electricity | 2 | 2014 | 97 | 0.190 |
Why?
|
| Transgenes | 1 | 2022 | 186 | 0.190 |
Why?
|
| Streptomyces lividans | 2 | 2012 | 16 | 0.180 |
Why?
|
| Precision Medicine | 2 | 2023 | 451 | 0.180 |
Why?
|
| Antibodies | 1 | 2023 | 357 | 0.180 |
Why?
|
| Molecular Sequence Data | 4 | 2014 | 3041 | 0.170 |
Why?
|
| Biological Transport | 3 | 2014 | 412 | 0.160 |
Why?
|
| Benzimidazoles | 3 | 2005 | 112 | 0.150 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2023 | 668 | 0.140 |
Why?
|
| Melanoma | 1 | 2023 | 497 | 0.140 |
Why?
|
| Hepcidins | 1 | 2017 | 5 | 0.140 |
Why?
|
| Receptors, Ghrelin | 1 | 2017 | 5 | 0.140 |
Why?
|
| Escherichia coli Proteins | 1 | 2019 | 190 | 0.140 |
Why?
|
| Protein Structure, Secondary | 2 | 2019 | 342 | 0.130 |
Why?
|
| Immunotherapy | 1 | 2023 | 763 | 0.130 |
Why?
|
| Cell Surface Display Techniques | 1 | 2015 | 16 | 0.120 |
Why?
|
| Immunoglobulin Fragments | 1 | 2015 | 23 | 0.120 |
Why?
|
| T-Lymphocytes | 1 | 2022 | 1316 | 0.120 |
Why?
|
| Models, Chemical | 2 | 2007 | 187 | 0.120 |
Why?
|
| Molecular Chaperones | 1 | 2015 | 127 | 0.110 |
Why?
|
| Nanostructures | 1 | 2015 | 89 | 0.110 |
Why?
|
| Ions | 1 | 2014 | 80 | 0.100 |
Why?
|
| Xenopus laevis | 1 | 2014 | 143 | 0.100 |
Why?
|
| Vanadates | 2 | 2004 | 32 | 0.100 |
Why?
|
| Cytoplasm | 1 | 2014 | 288 | 0.100 |
Why?
|
| Oocytes | 1 | 2014 | 227 | 0.100 |
Why?
|
| DNA Primers | 1 | 2014 | 548 | 0.100 |
Why?
|
| Cloning, Molecular | 1 | 2014 | 648 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 1 | 2019 | 1431 | 0.100 |
Why?
|
| Patch-Clamp Techniques | 1 | 2014 | 402 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 2 | 2012 | 750 | 0.100 |
Why?
|
| Protein Structure, Quaternary | 1 | 2012 | 103 | 0.090 |
Why?
|
| Genetic Vectors | 1 | 2014 | 446 | 0.090 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2014 | 220 | 0.090 |
Why?
|
| CRISPR-Cas Systems | 2 | 2023 | 98 | 0.090 |
Why?
|
| HLA Antigens | 2 | 2023 | 231 | 0.090 |
Why?
|
| Up-Regulation | 1 | 2014 | 741 | 0.090 |
Why?
|
| Protein Multimerization | 1 | 2012 | 196 | 0.090 |
Why?
|
| Edetic Acid | 1 | 2010 | 42 | 0.080 |
Why?
|
| Computational Biology | 1 | 2014 | 584 | 0.080 |
Why?
|
| Spin Labels | 1 | 2010 | 107 | 0.080 |
Why?
|
| Membrane Proteins | 1 | 2015 | 1276 | 0.070 |
Why?
|
| Dimerization | 2 | 2005 | 150 | 0.070 |
Why?
|
| Protein Binding | 2 | 2017 | 1561 | 0.070 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2005 | 282 | 0.070 |
Why?
|
| Neoplasms | 1 | 2022 | 3250 | 0.060 |
Why?
|
| Catalysis | 2 | 2005 | 216 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 2883 | 0.060 |
Why?
|
| Proteolipids | 1 | 2005 | 8 | 0.060 |
Why?
|
| Oxygen | 1 | 2010 | 788 | 0.060 |
Why?
|
| Reserpine | 1 | 2004 | 6 | 0.050 |
Why?
|
| Ethidium | 1 | 2004 | 13 | 0.050 |
Why?
|
| Structure-Activity Relationship | 2 | 2019 | 436 | 0.050 |
Why?
|
| Liposomes | 1 | 2004 | 101 | 0.050 |
Why?
|
| Hydrolysis | 1 | 2003 | 146 | 0.050 |
Why?
|
| Amino Acid Motifs | 1 | 2003 | 123 | 0.050 |
Why?
|
| Protein Folding | 1 | 2005 | 295 | 0.050 |
Why?
|
| Doxorubicin | 1 | 2004 | 304 | 0.050 |
Why?
|
| Genes, T-Cell Receptor alpha | 1 | 2022 | 3 | 0.050 |
Why?
|
| Genes, T-Cell Receptor beta | 1 | 2022 | 8 | 0.050 |
Why?
|
| Mutation | 3 | 2023 | 4374 | 0.050 |
Why?
|
| Gene Knock-In Techniques | 1 | 2022 | 29 | 0.050 |
Why?
|
| Gene Knockout Techniques | 1 | 2022 | 85 | 0.050 |
Why?
|
| Amino Acid Substitution | 1 | 2003 | 336 | 0.050 |
Why?
|
| Encephalitis | 1 | 2022 | 101 | 0.050 |
Why?
|
| Animals | 3 | 2019 | 28945 | 0.040 |
Why?
|
| Binding Sites | 2 | 2019 | 1167 | 0.040 |
Why?
|
| Fluorescent Dyes | 1 | 2002 | 262 | 0.040 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2016 | 308 | 0.040 |
Why?
|
| Models, Biological | 1 | 2007 | 1815 | 0.040 |
Why?
|
| Patient Safety | 1 | 2022 | 223 | 0.040 |
Why?
|
| Epitope Mapping | 1 | 2019 | 18 | 0.040 |
Why?
|
| Biopsy | 1 | 2022 | 1220 | 0.040 |
Why?
|
| Epitopes | 1 | 2019 | 258 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2023 | 1103 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2004 | 2092 | 0.030 |
Why?
|
| Disease Progression | 1 | 2022 | 1568 | 0.030 |
Why?
|
| Caloric Restriction | 1 | 2017 | 15 | 0.030 |
Why?
|
| Ghrelin | 1 | 2017 | 29 | 0.030 |
Why?
|
| Growth Hormone | 1 | 2017 | 99 | 0.030 |
Why?
|
| Fasting | 1 | 2017 | 164 | 0.030 |
Why?
|
| Eating | 1 | 2017 | 165 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 1125 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2019 | 1267 | 0.030 |
Why?
|
| Detergents | 1 | 2015 | 33 | 0.030 |
Why?
|
| Intestine, Small | 1 | 2017 | 310 | 0.030 |
Why?
|
| Peptide Library | 1 | 2015 | 85 | 0.030 |
Why?
|
| Cryoelectron Microscopy | 1 | 2016 | 115 | 0.030 |
Why?
|
| Bariatric Surgery | 1 | 2017 | 207 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 847 | 0.030 |
Why?
|
| Liver | 1 | 2017 | 1238 | 0.020 |
Why?
|
| Rats | 1 | 2017 | 4154 | 0.020 |
Why?
|
| Phenylalanine | 1 | 2010 | 36 | 0.020 |
Why?
|
| Allosteric Regulation | 1 | 2010 | 70 | 0.020 |
Why?
|
| Hydrogen Bonding | 1 | 2010 | 154 | 0.020 |
Why?
|
| Shaker Superfamily of Potassium Channels | 1 | 2010 | 51 | 0.020 |
Why?
|
| Humans | 4 | 2023 | 96127 | 0.020 |
Why?
|
| Cysteine | 1 | 2010 | 146 | 0.020 |
Why?
|
| Kinetics | 1 | 2010 | 1562 | 0.020 |
Why?
|
| Disulfides | 1 | 2005 | 65 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 2005 | 92 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2005 | 422 | 0.010 |
Why?
|
| Adenosine Triphosphatases | 1 | 2005 | 156 | 0.010 |
Why?
|
| Mice | 1 | 2017 | 12562 | 0.010 |
Why?
|
| Male | 1 | 2017 | 45870 | 0.010 |
Why?
|
| Female | 1 | 2017 | 50063 | 0.010 |
Why?
|